Scott Musick, DO
Family Medicine · Bentonville, ARNPI 1386672392
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $88,088 of the $102,352 with a category attached, or 86.1%. 28 manufacturers reported payments, led by Amgen at 49.2% of the total. Reporting peaked in 2022 at $26,880 and has fallen 77.7% since, to $6,007 in 2025. Among family medicine clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 313 payments — averaging $327.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$50K
- AbbVie$17K
- AstraZeneca$16K
- Bayer$12K
- Exact Sciences$4K
- Novo Nordisk$580
- plus $3K from 22 others
What the payments were for
- Consulting fees$3,5003%
- Speaking & faculty fees$88,08886%
- Travel & lodging$2,5312%
- Food & beverage$7,9558%
- Education$2770%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 69 | $50,306 |
| AbbVie(2 entities) | 88 | $17,442 |
| AstraZeneca | 51 | $15,809 |
| Bayer | 17 | $11,910 |
| Exact Sciences | 13 | $3,641 |
| Novo Nordisk | 13 | $580 |
| Boehringer Ingelheim | 9 | $442 |
| Dexcom, Inc. | 7 | $365 |
| GSK | 8 | $290 |
| Astellas Pharma US Inc | 4 | $286 |
| Inari Medical, Inc. | 2 | $264 |
| Esperion Therapeutics, Inc. | 2 | $187 |
| Amarin Pharma, Inc. | 1 | $122 |
| Clarus Therapeutics Inc. | 1 | $108 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $105 |
| Lilly USA, LLC | 2 | $83 |
| Pfizer | 3 | $82 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Merck | 3 | $50 |
| Supernus Pharmaceuticals, Inc. | 3 | $49 |
| Corium, LLC | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $27 |
| Gilead | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$49,497
- FARXIGA$14,525
- Kerendia$11,800
- UBRELVY$9,972
- VRAYLAR$6,450
- Cologuard Collection Kit$3,500
- The Cologuard Plus Collection Kit$500
- JATENZO$323
- DEXCOM G7 GSS (161)$270
- AIRSUPRA$250
- QULIPTA$231
- JARDIANCE$218
- FLOWTRIEVER CATHETER, S$166
- CT THROMBECTOMY SYSTEM KIT$166
- DEXCOM STELO GLUCOSE BIOSENSOR$145
- Tresiba$125
- Victoza$125
- Xultophy 100/3.6$125
- TRELEGY ELLIPTA$124
- Vascepa$122
How this compares
$102,352 in reported general payments places this provider in the 95th percentile of 1,347 family medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 292 | $224,907 |
| EliquisApixaban | 117 | $138,114 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 151 | $133,155 |
| OzempicSemaglutide | 106 | $126,916 |
| JardianceEmpagliflozin | 100 | $100,964 |
| XareltoRivaroxaban | 51 | $69,526 |
| MyrbetriqMirabegron | 73 | $68,563 |
| LinzessLinaclotide | 44 | $44,684 |
| CreonLipase/Protease/Amylase | 31 | $43,133 |
| MounjaroTirzepatide | 29 | $42,917 |
| VraylarCariprazine Hcl | 22 | $31,538 |
| Breo ElliptaFluticasone/Vilanterol | 32 | $29,146 |
| Repatha SureclickEvolocumab | 31 | $28,866 |
| JanuviaSitagliptin Phosphate | 27 | $28,056 |
| KerendiaFinerenone | 25 | $26,662 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere, Symbicort | $15,809 | $250,942344 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $290 | $162,302183 claims |
| Novo NordiskOzempic, Rybelsus | $580 | $146,047118 claims |
| PfizerEliquis | $82 | $138,114117 claims |
| AbbVieLinzess, Creon, Vraylar, Synthroid | $17,442 | $124,561158 claims |
| Boehringer IngelheimJardiance | $442 | $100,964100 claims |
| Astellas Pharma US IncMyrbetriq | $286 | $68,56373 claims |
| Lilly USA, LLCMounjaro, Trulicity | $83 | $61,32645 claims |
| MerckJanuvia, Belsomra | $50 | $34,32042 claims |
| BayerKerendia | $11,910 | $26,66225 claims |
| Collegium Pharmaceutical, Inc.Belbuca | $18 | $6,93913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,347 family medicine providers in Arkansas.
Other family medicine in Bentonville
- Craig LevoyBentonville$30K
- Rossitza HristoskovaBentonville$14K
- Graeme ArcherBentonville$13K
- Glenn GibbonsFort Smith$179K
- Hetal PatelParagould$147K
- David GersonSherwood$119K
- Broderick EatonWynne$49K
- Allen BeachyFort Smith$21K
- Hunter CarringtonHot Springs$20K
- Harold BettonLittle Rock$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.